Back to Journals » Breast Cancer: Targets and Therapy » Volume 14

Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States

Total article views   HTML views PDF downloads Totals
4,348 Dovepress* 3,920+ 185 4,105
PubMed Central* 428 199 627
Totals 4,348 384 4,732
*Since 9 December 2022

View citations on PubMed Central and Google Scholar